Radius Health   Report issue

Contributed to NME For profit Phase 1 Phase 2 Phase 3 Phase 4
Founded: Waltham MA United States (2005)

Organization Overview

First Clinical Trial
2007
NCT00542425
First Marketed Drug
2005
sulindac (clinoril)
First NDA Approval
2017
abaloparatide (tymlos)
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Nuvios | Radius Health, Inc. | RADIUS HEALTH INC | Radius Pharmaceuticals, Inc. | RADIUS PHARMS